Similar Articles
The Correlation Between The Expanded Disability Status Scale Functional Systems and Health Related Quality of Life: Analysis of 183 Multiple Sclerosis Patients
Egemen İDİMAN, Serkan ÖZAKBAŞ, Nuray YOZBATIRAN, Fatma UZUNEL, Meral OĞUZ, Fatma KÜRŞAD
Analysis of Factors Effecting Cerebral Atrophy in Patients with Long Term Multiple Sclerosis
Mutlu CİHANGİROĞLU, M. Said BERİLGEN, Hüseyin ÖZDEMİR, Serpil BULUT, Hadi UYSAL, Fatma KANSIZ
Usage of Multiple Sclerosis Functional Composite in Multiple Sclerosis
Serkan ÖZAKBAŞ, Egemen İDİMAN, Beril DÖNMEZ, Burcu ÖRMECİ
Changes in Health-related Quality of Life Measured by Multiple Sclerosis International Quality of Life (version 1) in the Two Year Follow-up in MS Patients with Low Disability
Egemen İDİMAN, Serkan ÖZAKBAŞ, Fatma UZUNEL
Heterogenous Enhancement Pattern of Tumour-Like Multiple Sclerosis
Selim Serter, Serdar Tarhan, Deniz Selçuki, Şebnem Örgüç
Tumour Necrosis Factor-Alpha Alone is not Predictive of Relapses in Multiple Sclerosis.
Egemen İDİMAN, Hakkı BAHAR, İhsan Şükrü ŞENGÜN, Göksemin ACAR, Barış BAKLAN, Murat SAYAN, Huriye AYDIN, Tuncer TOKLU, Serkan ÖZAKBAŞ
Demographic and Clinical Features in Primary Progressive Multiple Sclerosis
Serkan ÖZAKBAŞ, Egemen İDİMAN, Burak PAKÖZ, Burcu ÖRMECİ, Beril DÖNMEZ
Supportive Group Therapy in Multiple Sclerosis
Şule Özden TOPKAYA, Meral OĞUZ, Fatma UZUNEL, Serkan ÖZAKBAŞ, Köksal ALPTEKİN, Egemen İDİMAN
Causes of Death in Multiple Sclerosis: Cross-sectional Analysis of 16 Years Period
Serkan ÖZAKBAŞ, Burak PAKÖZ, İhsan Şükrü ŞENGÜN, Barış BAKLAN, Göksemin DEMİR, Bülent ÜNLÜ, Zuhal BAHAR, Egemen İDİMAN
A Case of Mu/tiple Sclerosis Presenting As Unilateral Papillitis
Nurgül YILMAZ, Ebru ÖZAY, Funda AÇIKGÖZ, Nursel AYDIN
Multimodal Evoked Potentialsin Follow-up of Treatment of Multiple Sclerosis With lnterferon Beta-1 a
Serkan ÖZAKBAŞ, Raif ÇAKMUR, Vesile ÖZTÜRK, Egemen İDİMAN, Fethi İDİMAN
lnterferon Beta-1b In TheTreatment Of Relapsing Remitting Multiple Sclerosis:Clinical and Magnetic Resonance lmaging Results
Serkan ÖZAKBAŞ, Egemen İDİMAN, Handan ÇAKMAKÇI, İlhami KOVANLIKAYA
Cytokines in Multiple Sclerosis
A. ALTINTAŞ, O. KANTARCI, S. SAİP, A. SİVA, S. ÖZTUZCU, N. HEKİM, P. BOZKURT
Beta lnterferon-lA Treatment in Multipl Sclerosis and Cognitive Functions
E. İDİMAN, G. G. YENER, G. AKDAL, S. ÖZAKBAŞ
Effect of General Anesthesia on the Emergence of Parkinson's Disease
M. Cenk AKBOSTANCI, Funda TAN, Sıla USAR, Hatice BALABAN, Nermin MUTLUER
The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.
D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN
Clinical Scales for Multiple Sclerosis
Kadriye ARMUTLU, Rana KARABUDAK
HLA Tissue Antigens in Multiple Sclerosis
Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL
Serum Vitamin B12 and Folate Levels in Multiple Sclerosis
H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER
Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.
Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM